Company Overview

Development Stage

About the Company

[Summary] 创新型细胞治疗药物的研发商

华夏英泰(北京)生物技术有限公司于2018年3月由著名免疫学家林欣教授领衔创立,为清华大学技术成果转化的典型范例。公司专注于以 TCR-T 为代表的针对癌症和其他疾病的细胞免疫治疗产品的开发及商业化,拥有两大独有技术平台 STAR-T 和 TCR-T。基于两大核心技术平台和成熟的工艺开发及质量控制的产业化平台,公司已与多家医院合作启动了7项备案的“First-in-human”临床研究,完成了20多例患者TCR-T/STAR-T/CAR-T细胞的回输治疗,取得了积极的临床安全性与有效性数据,部分项目正在进行新药IND申报准备。华夏英泰成立两年内,已建立了50人的团队,吸引了数位具有丰富药物开发经验的专业人才加入,核心技术人员均为知名高校毕业的免疫学或医学博士。公司已获得了近亿元股权融资,申请了6项新技术发明专利,获得了中关村高新技术企业、北京市海淀区胚芽企业、中关村示范区科技型小微企业、中关村金种子企业等称号,受到了北京市科委等相关部门的大力扶持,与清华大学肿瘤免疫研究室开展了深度合作。“科学创新,攻克癌症;华夏英泰,共创未来”是公司的发展愿景;研发优势明显、技术驱动创新,双技术平台、管线丰富、拓展性好,是华夏英泰的鲜明特色;产业化能力强、推进速度快是我们追求的目标,正在成为“研发端具有技术,研发优势能快速转化为临床批件的企业”。网址:*

Expand
Information is aggregated from the web and may not be exact. For reference only.
Information incorrect? Claim this company to edit

华夏英泰 Financing History (8 rounds)

Manage
C轮
Capital Market Favor
Latest Financing Round
  • Date: ?
  • Amount: 2亿人民币
  • Investor: 正心谷资本,复旦科创

华夏英泰 How Fast Is Hiring Growing? (4 open positions)

Manage
?
Growth Rate
2026 vs 2025
  • 2025: Up 45%
  • 2024: Down 52%
  • 2023: Down 8%
  • 2022: Up 9%
华夏英泰 Year-by-Year Hiring:
* Hiring was generally low during 2020-2022 due to the pandemic
华夏英泰 Campus Recruitment & Advanced Degree Talent Demand
Master's 1
Note: How fast is hiring at 华夏英泰(北京)生物技术有限公司 growing? 华夏英泰2025: 16 openings (up 45%), 2024: 11 openings (down 52%), 2023: 23 openings (down 8%), 2022: 25 openings (up 9%), 2021: 23 openings. A rising curve may indicate expansion; a falling curve may indicate slower growth or good retention. Based on publicly available data, for reference only.

华夏英泰 Master's Degree Job Demand Analysis

(More)
?
Growth Rate
2026 vs 2025
  • 2025: Down 25%
  • 2024: Down 60%
  • 2023: Down 29%
  • 2022: Up 367%
华夏英泰 Master's Hiring by Year:
* Hiring was generally low during 2020-2022 due to the pandemic
How fast is master's hiring at 华夏英泰(北京)生物技术有限公司 growing? 华夏英泰Master's recruitment over the years: 2025: 3 openings (down 25%), 2024: 4 openings (down 60%), 2023: 10 openings (down 29%), 2022: 14 openings (up 367%), 2021: 3 openings.

华夏英泰 Doctoral Degree Job Demand Analysis

(More)
-33%
Growth Rate
2026 vs 2025
  • 2025: Up 200%
  • 2024: Flat 0%-
  • 2023: Down 50%
  • 2022: Up 100%
华夏英泰 Doctoral Hiring by Year: 2026 — 1 fewer jobs than 2025
* Hiring was generally low during 2020-2022 due to the pandemic
How fast is doctoral hiring at 华夏英泰(北京)生物技术有限公司 growing? 华夏英泰Doctorate recruitment over the years: 2026: 2 openings (down 33%), 2025: 3 openings (up 200%), 2024: 1 openings (flat), 2023: 1 openings (down 50%), 2022: 2 openings (up 100%), 2021: 1 openings.

华夏英泰 R&D Strength (Technical Talent Demand)

(More)
How is the demand for technical talent at 华夏英泰(北京)生物技术有限公司? Based on an analysis of 华夏英泰's job postings over the past year, "医疗卫生/美容保健类" demand: 45.8%, "生物/制药/化工/环保类": 16.7%. For reference only.

华夏英泰 — What Are the Salaries Like? (24 records)

Manage
华夏英泰 Salary Overview
salary range: 8K - 50K, 75% of roles pay ¥15-50K
Note: salary statistics are based on 24 salary records from the past year and depend on the job sample. For reference only.
How is the salary at 华夏英泰(北京)生物技术有限公司?华夏英泰75% of positions earn 15-50K, Undergraduate salary: ¥。医疗卫生/美容保健类 average salary ¥33.1K。 Note: Based on analysis of job postings, does not represent current on-the-job positions; system stability may affect objectivity. For reference only.Data inaccurate? Let us know

Salaries for hot jobs of 华夏英泰

(More)
Are salaries high at 华夏英泰(北京)生物技术有限公司? We provide: 临床,医学经理,行政,项目经理,ra,人事,人力,开发主管,监察,bd,pm,事主管,分析,研究助理,质量. Click to view detailed salary analysis by job.

华夏英泰 honors, qualifications & industry associations

华夏英泰 Related Industry Tags

Job Category

  • 医疗卫生/美容保健类
    46.7% of total 46.7%
  • 经营管理类
    40% of total 40%
  • 销售类
    20% of total 20%
  • 人力资源类
    13.3% of total 13.3%

Education

  • 本科
    53.3% of total 53.3%
  • 硕士
    30% of total 30%
  • 博士
    13.3% of total 13.3%
  • 大专
    3.3% of total 3.3%

Experience

  • 5-10年
    40% of total 40%
  • 3-5年
    30% of total 30%
  • 不限
    26.7% of total 26.7%
  • 1-3年
    3.3% of total 3.3%
View Detailed Analysis

What does 华夏英泰(北京)生物技术有限公司 require? Who is 华夏英泰 hiring? 华夏英泰 recruitment: 医疗卫生/美容保健类占比最多占46.7%,其次是经营管理类占40%. What education can get in at 华夏英泰? 本科占比最多占53.3%,其次是硕士占30%. High education required at 华夏英泰? 硕士占30%,博士占13.3%. Work experience required at 华夏英泰? 5-10年占比最多占40%,其次是3-5年占30%. Where are the job locations at 华夏英泰? 北京占比最多占100%. Based on job postings from the past year, for reference only.

Business Registration

Provided by

Operating Status: 开业
Registered Capital: 298.5803万(元)
Legal Representative: 郑洪丽
Date Established:
Credit Code: 91110108MA01B5CY6U
Registered Address: 北京市海淀区小营西路10号院1号楼和盈中心A座3层324室

People who follow 华夏英泰 also follow

华夏英泰 Competitors (Similar Companies)

基因合成 生物科技/生物工程 试剂 分子生物学
“一家拥有70余年辉煌历史的制药企业”
医药 生物医药 新药研发 CRO
“Large-scale pharmaceutical distribution enterprise”
制药/药业 医药 药物研发 新药研发
“Although the processing is complicated, we dare not save labor; althou”
“Building a world-class hospital and leading the reform of the healthca”
生命科学 生物信息 分子育种 心血管疾病检测
酵母 动物营养 动物食品 兽医
“Core Mission: Safeguarding Human Health with Life Sciences”
“Life Sciences and Integrated Medicine”
“药物体外筛选技术和早期药物机理研究”
手术器械 骨科医疗器械 医疗器械 3D打印
生物科技/生物工程 医药 生命科学 生命科学研究
诊断试剂 CRO 试剂 分子生物学

Report

*Reason:

Radical political or ideological topics
Advertising or spam
Pornographic or vulgar content
Obscene language or personal attacks
Other

Congratulations, submitted successfully!

Your edit is under review. You will be notified by email within 1 business day.

Submission failed.

Followed successfully. We'll notify you of any company updates.

Help others learn about this company, add my impression of this company»

Log in with the following accounts to save your follows

Followed successfully, we'll notify you of any company updates